252 related articles for article (PubMed ID: 17035319)
1. Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity.
Rovedo M; Longnecker R
J Virol; 2007 Jan; 81(1):84-94. PubMed ID: 17035319
[TBL] [Abstract][Full Text] [Related]
2. Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection.
Rechsteiner MP; Berger C; Zauner L; Sigrist JA; Weber M; Longnecker R; Bernasconi M; Nadal D
J Virol; 2008 Feb; 82(4):1739-47. PubMed ID: 18057232
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency.
Fruehling S; Swart R; Dolwick KM; Kremmer E; Longnecker R
J Virol; 1998 Oct; 72(10):7796-806. PubMed ID: 9733815
[TBL] [Abstract][Full Text] [Related]
4. Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction.
Swart R; Fruehling S; Longnecker R
Virology; 1999 Oct; 263(2):485-95. PubMed ID: 10544120
[TBL] [Abstract][Full Text] [Related]
5. The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases.
Ikeda M; Ikeda A; Longan LC; Longnecker R
Virology; 2000 Mar; 268(1):178-91. PubMed ID: 10683340
[TBL] [Abstract][Full Text] [Related]
6. PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins.
Ikeda M; Ikeda A; Longnecker R
J Virol; 2001 Jun; 75(12):5711-8. PubMed ID: 11356981
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation.
Incrocci R; Hussain S; Stone A; Bieging K; Alt LA; Fay MJ; Swanson-Mungerson M
Cell Immunol; 2015 Oct; 297(2):108-19. PubMed ID: 26255694
[TBL] [Abstract][Full Text] [Related]
8. Latent Membrane Protein 2 (LMP2).
Cen O; Longnecker R
Curr Top Microbiol Immunol; 2015; 391():151-80. PubMed ID: 26428374
[TBL] [Abstract][Full Text] [Related]
9. Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A.
Fish K; Comoglio F; Shaffer AL; Ji Y; Pan KT; Scheich S; Oellerich A; Doebele C; Ikeda M; Schaller SJ; Nguyen H; Muppidi J; Wright GW; Urlaub H; Serve H; Staudt LM; Longnecker R; Oellerich T
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26318-26327. PubMed ID: 33020271
[TBL] [Abstract][Full Text] [Related]
10. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction.
Fruehling S; Longnecker R
Virology; 1997 Sep; 235(2):241-51. PubMed ID: 9281504
[TBL] [Abstract][Full Text] [Related]
11. Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases.
Winberg G; Matskova L; Chen F; Plant P; Rotin D; Gish G; Ingham R; Ernberg I; Pawson T
Mol Cell Biol; 2000 Nov; 20(22):8526-35. PubMed ID: 11046148
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn.
Rovedo M; Longnecker R
J Virol; 2008 Sep; 82(17):8520-8. PubMed ID: 18579586
[TBL] [Abstract][Full Text] [Related]
13. The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility.
Allen MD; Young LS; Dawson CW
J Virol; 2005 Feb; 79(3):1789-802. PubMed ID: 15650203
[TBL] [Abstract][Full Text] [Related]
14. LMP2A does not require palmitoylation to localize to buoyant complexes or for function.
Katzman RB; Longnecker R
J Virol; 2004 Oct; 78(20):10878-87. PubMed ID: 15452208
[TBL] [Abstract][Full Text] [Related]
15. The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation.
Shah KM; Stewart SE; Wei W; Woodman CB; O'Neil JD; Dawson CW; Young LS
Oncogene; 2009 Nov; 28(44):3903-14. PubMed ID: 19718044
[TBL] [Abstract][Full Text] [Related]
16. Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells.
Rechsteiner MP; Berger C; Weber M; Sigrist JA; Nadal D; Bernasconi M
J Gen Virol; 2007 May; 88(Pt 5):1454-1459. PubMed ID: 17412973
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.
Swanson-Mungerson MA; Caldwell RG; Bultema R; Longnecker R
J Virol; 2005 Jun; 79(12):7355-62. PubMed ID: 15919890
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice.
Caldwell RG; Brown RC; Longnecker R
J Virol; 2000 Feb; 74(3):1101-13. PubMed ID: 10627520
[TBL] [Abstract][Full Text] [Related]
19. A mutation in Epstein-Barr virus LMP2A reveals a role for phospholipase D in B-Cell antigen receptor trafficking.
Snyder MD; Pierce SK
Traffic; 2006 Aug; 7(8):993-1006. PubMed ID: 16882041
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR.
Dykstra ML; Longnecker R; Pierce SK
Immunity; 2001 Jan; 14(1):57-67. PubMed ID: 11163230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]